These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 22693730)

  • 21. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
    D'Andrea MR; Limiti MR; Bari M; Zambenedetti P; Montagutti A; Ricci F; Pappagallo GL; Sartori D; Vinante O; Mingazzini PL
    Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ki-67 expression in operable breast cancer: a comparative study of immunostaining and a real-time RT-PCR assay.
    Potemski P; Pluciennik E; Bednarek AK; Kusinska R; Kubiak R; Jesionek-Kupnicka D; Watala C; Kordek R
    Pathol Res Pract; 2006; 202(7):491-5. PubMed ID: 16678980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue microarray validation: a methodologic study with special reference to lung cancer.
    Karlsson C; Bodin L; Piehl-Aulin K; Karlsson MG
    Cancer Epidemiol Biomarkers Prev; 2009 Jul; 18(7):2014-21. PubMed ID: 19531681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ki-67 and cyclin A--prognostic factors in breast cancer. Time to introduce proliferation markers in clinical routine].
    Ahlin C; Fernö M; Amini RM; Tolockiene E; Blomqvist C; Bergh J; Fjällskog ML
    Lakartidningen; 2010 Mar 10-16; 107(10):672-5. PubMed ID: 20402250
    [No Abstract]   [Full Text] [Related]  

  • 25. An unusual triple-negative breast carcinoma.
    Shousha S; Peston D; Gojis O; Palmieri C
    Histopathology; 2009 Sep; 55(3):364-6. PubMed ID: 19723156
    [No Abstract]   [Full Text] [Related]  

  • 26. Triple-negative breast cancers: unique clinical presentations and outcomes.
    Billar JA; Dueck AC; Stucky CC; Gray RJ; Wasif N; Northfelt DW; McCullough AE; Pockaj BA
    Ann Surg Oncol; 2010 Oct; 17 Suppl 3():384-90. PubMed ID: 20853062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue microarray-based studies of patients with lymph node negative breast carcinoma show that met expression is associated with worse outcome but is not correlated with epidermal growth factor family receptors.
    Tolgay Ocal I; Dolled-Filhart M; D'Aquila TG; Camp RL; Rimm DL
    Cancer; 2003 Apr; 97(8):1841-8. PubMed ID: 12673709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathologic characteristics and prognosis of young patients with breast cancer.
    Han JG; Jiang YD; Zhang CH; Pang D; Zhang M; Wang YB; Xue WN; Sun Q
    Breast; 2011 Aug; 20(4):370-2. PubMed ID: 21392995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma.
    Faratian D; Munro A; Twelves C; Bartlett JM
    Histopathology; 2009 Jan; 54(2):254-7. PubMed ID: 19207951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reply to "IHC for Her2 with CBE356 antibody is a more accurate predictor of Her2 gene amplification by FISH than HercepTest in breast carcinoma".
    Egervari K; Szollosi Z; Nemes Z
    J Clin Pathol; 2006 Jun; 59(6):665; author reply 665-6. PubMed ID: 16731611
    [No Abstract]   [Full Text] [Related]  

  • 31. Triple-negative breast cancer: what the radiologist needs to know.
    Whitman GJ; Albarracin CT; Gonzalez-Angulo AM
    Semin Roentgenol; 2011 Jan; 46(1):26-39. PubMed ID: 21134526
    [No Abstract]   [Full Text] [Related]  

  • 32. Significance of epidermal growth factor receptor expression in breast cancer.
    Badovinac-Crnjevic T; Jakic-Razumovic J; Podolski P; Pleština S; Sarčević B; Munjas R; Vrbanec D
    Med Oncol; 2011 Dec; 28 Suppl 1():S121-8. PubMed ID: 21104342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HER2 signatures in breast cancer: ready to go to print?
    Eichhorn PJ; Baselga J
    J Clin Oncol; 2010 Apr; 28(11):1809-10. PubMed ID: 20231675
    [No Abstract]   [Full Text] [Related]  

  • 34. Differential subcellular expression of protein kinase C betaII in breast cancer: correlation with breast cancer subtypes.
    Gökmen-Polar Y; Mehta R; Tuzmen S; Mousses S; Thorat MA; Sanders KL; Turbin D; Leung S; Huntsman DG; Sledge GW; Badve S
    Breast Cancer Res Treat; 2010 Nov; 124(2):327-35. PubMed ID: 20099025
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective study of breast cancer subtypes: the risk of relapse and the relations with treatments.
    Wang Y; Yin Q; Yu Q; Zhang J; Liu Z; Wang S; Lv S; Niu Y
    Breast Cancer Res Treat; 2011 Nov; 130(2):489-98. PubMed ID: 21837481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HER-2: a biomarker at the crossroads of breast cancer immunotherapy and molecular medicine.
    Pupa SM; Tagliabue E; Ménard S; Anichini A
    J Cell Physiol; 2005 Oct; 205(1):10-8. PubMed ID: 15887236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunomorphological characteristics of primary and recurrent breast neoplasms].
    Volchenko NN; Zavalishina LE; Shimbireva IB; Frank GA
    Arkh Patol; 1998; 60(4):4-7. PubMed ID: 9791688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 in breast cancer. Its relation to histological grade, lymph-node status, hormone receptors, cell-proliferation fraction (ki-67) and c-erbB-2. Immunohistochemical study of 153 cases.
    Sirvent JJ; Salvadó MT; Santafé M; Martínez S; Brunet J; Alvaro T; Palacios J
    Histol Histopathol; 1995 Jul; 10(3):531-9. PubMed ID: 7579801
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The routine immunohistochemical evaluation in Paget disease of the nipple.
    Marczyk E; Kruczak A; Ambicka A; Mularz K; Harazin-Lechowska A; Moskal J; Sokołowski A; Mituś J; Ryś J
    Pol J Pathol; 2011 Dec; 62(4):229-35. PubMed ID: 22246908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy.
    Parton M; Krajewski S; Smith I; Krajewska M; Archer C; Naito M; Ahern R; Reed J; Dowsett M
    Clin Cancer Res; 2002 Jul; 8(7):2100-8. PubMed ID: 12114409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.